期刊文献+

Inhibition of beta-site amyloid precursor protein-cleaving enzyme and beta-amyloid precursor protein genes in SK-N-SH cells

Inhibition of beta-site amyloid precursor protein-cleaving enzyme and beta-amyloid precursor protein genes in SK-N-SH cells
下载PDF
导出
摘要 BACKGROUND: Previous studies have demonstrated that Piper futokadsura stem selectively inhibits expression of amyloid precursor protein (APP) at the mRNA level. In addition, the piperlonguminine (A) and dihydropiperlonguminine (B) components (1 : 0.8), which can be separated from Futokadsura stem, selectively inhibit expression of the APP at mRNA and protein levels. OBJECTIVE: Based on previous findings, the present study investigated the effects of β-site amyloid precursor protein cleaving enzyme (BACE1) and APP genes on the production of β-amyloid peptide 42 (Aβ42) in human neuroblastoma cells (SK-N-SH cells) using small interfering RNAs (siRNAs) and A/B components separated from Futokadsura stem, respectively. DESIGN, TIME AND SETTING: A gene interference-based randomized, controlled, in vitro experiment was performed at the Key Laboratory of Cardiovascular Remodeling and Function Research, Ministries of Education and Public Health, and Institute of Pharmacologic Research, School of Pharmaceutical Science & Department of Biochemistry, School of Medicine, Shandong University between July 2006 and December 2007. MATERIALS: SK-N-SH cells were provided by Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences, Shanghai, China; mouse anti-human BACE1 monoclonal antibody was purchased from R&D Systems, USA; mouse anti-human APP monoclonal antibody was purchased from Cell Signaling Technology, USA; and horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG was provided by Sigma, USA. METHODS: The human BACE1 cDNA sequence was obtained from NCBI website (www.ncbi.nlm.nih.gov/sites/entrez). Three pairs of siRNAs, specific to human BACE1 gene, were synthesized through the use of Silencer pre-designed siRNA specification, and were transfected into SK-N-SH cells with siPORT NeoFX transfection agent to compare the effects of different concentrations of siRNAs (10-50 nmol/L) on SK-N-SH cells. Futokadsura stem was separated and purified with chemical methods, and the crystal was composed of A/B components, with an A to B ratio of 1:0.8. The A/B (1 : 0.8) components were added to the SK-N-SH cells at different concentrations (13.13, 6.56, and 3.28 mg/mL). MAIN OUTCOME MEASURES: Using RT-PCR and Western blot methods, BACE1 and APP expression at mRNA and protein levels was detected in SK-N-SH cells following treatment with different siRNAs and concentrations of Futokadsura stem-separated A/B components, respectively. Altered Aβ42 secretion by SK-N-SH cells was determined by ELISA. RESULTS: BACE1 mRNA and protein levels were significantly suppressed by 40 and 50 nmol/L siRNAs at 48 hours post-transfection. A/B components (1 : 0.8), which were separated from Futokadsura stem, selectively inhibited mRNA and protein expression of APP in SK-N-SH cells. Aβ42 secretion by SK-N-SH cells was significantly decreased following treatment with siRNAs or A/B components. CONCLUSION: Inhibition of BACE1 and APP genes by various materials and methods efficiently decreased production of Aβ42. BACKGROUND: Previous studies have demonstrated that Piper futokadsura stem selectively inhibits expression of amyloid precursor protein (APP) at the mRNA level. In addition, the piperlonguminine (A) and dihydropiperlonguminine (B) components (1 : 0.8), which can be separated from Futokadsura stem, selectively inhibit expression of the APP at mRNA and protein levels. OBJECTIVE: Based on previous findings, the present study investigated the effects of β-site amyloid precursor protein cleaving enzyme (BACE1) and APP genes on the production of β-amyloid peptide 42 (Aβ42) in human neuroblastoma cells (SK-N-SH cells) using small interfering RNAs (siRNAs) and A/B components separated from Futokadsura stem, respectively. DESIGN, TIME AND SETTING: A gene interference-based randomized, controlled, in vitro experiment was performed at the Key Laboratory of Cardiovascular Remodeling and Function Research, Ministries of Education and Public Health, and Institute of Pharmacologic Research, School of Pharmaceutical Science & Department of Biochemistry, School of Medicine, Shandong University between July 2006 and December 2007. MATERIALS: SK-N-SH cells were provided by Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences, Shanghai, China; mouse anti-human BACE1 monoclonal antibody was purchased from R&D Systems, USA; mouse anti-human APP monoclonal antibody was purchased from Cell Signaling Technology, USA; and horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG was provided by Sigma, USA. METHODS: The human BACE1 cDNA sequence was obtained from NCBI website (www.ncbi.nlm.nih.gov/sites/entrez). Three pairs of siRNAs, specific to human BACE1 gene, were synthesized through the use of Silencer pre-designed siRNA specification, and were transfected into SK-N-SH cells with siPORT NeoFX transfection agent to compare the effects of different concentrations of siRNAs (10-50 nmol/L) on SK-N-SH cells. Futokadsura stem was separated and purified with chemical methods, and the crystal was composed of A/B components, with an A to B ratio of 1:0.8. The A/B (1 : 0.8) components were added to the SK-N-SH cells at different concentrations (13.13, 6.56, and 3.28 mg/mL). MAIN OUTCOME MEASURES: Using RT-PCR and Western blot methods, BACE1 and APP expression at mRNA and protein levels was detected in SK-N-SH cells following treatment with different siRNAs and concentrations of Futokadsura stem-separated A/B components, respectively. Altered Aβ42 secretion by SK-N-SH cells was determined by ELISA. RESULTS: BACE1 mRNA and protein levels were significantly suppressed by 40 and 50 nmol/L siRNAs at 48 hours post-transfection. A/B components (1 : 0.8), which were separated from Futokadsura stem, selectively inhibited mRNA and protein expression of APP in SK-N-SH cells. Aβ42 secretion by SK-N-SH cells was significantly decreased following treatment with siRNAs or A/B components. CONCLUSION: Inhibition of BACE1 and APP genes by various materials and methods efficiently decreased production of Aβ42.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2009年第6期418-425,共8页 中国神经再生研究(英文版)
基金 the National Natural Science Foundation of China,No. NSFC-3027164
关键词 Alzheimer's disease β-site amyloJd precursor protein cleaving enzyme amyloid precursor protein small interfering RNA piperlonguminine dihydropiperlonguminine Futokadsura stem Alzheimer's disease β-site amyloJd precursor protein cleaving enzyme amyloid precursor protein small interfering RNA piperlonguminine dihydropiperlonguminine Futokadsura stem
  • 相关文献

参考文献2

二级参考文献16

  • 1Sambamurti K, Hardy J, Refolo LM, Lahiri DK. Targeting APP metabolism for the treatment of Alzheimer's disease.Drug Dev Res 2002; 56:211-27.
  • 2Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.Science 2002; 297: 353-6.
  • 3Pinnix I, Musunuru U, Tun H, Sridharan A, Golde T, Eckman C, et al. A novel γ-secretase assay based on detection of the putative C-terminal fragment-γof amyloid β protein precursor. J Biol Chem 2001; 276: 481-7.
  • 4Struhl G, Adachi A. Nuclear access and action of notch in vivo. Cell 1998; 93: 649-60.
  • 5De Strooper B, Annaert W, Cupers E Saftig E Craessaerts K, Mumm JS, et al. A presenilin- 1-dependent γ-secretaselike protease mediates release of Notch intracellular domain.Nature 1999; 398:518-22.
  • 6De Strooper B, Annaert W. Where Notch and Wnt signaling meet. The presenilin hub. J Cell Biol 2001; 152: F17-20.
  • 7Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M,Takahashi Y, et al. The role of presenilin cofactors in the γ-secretase complex. Nature 2003; 422:438-41.
  • 8Mark S. Duxbury MA, Edward E. Whang MD. RNA interference: a practical approach. J Surg Res 2004; 117:339-44.
  • 9Omi K, Tokunaga K, Hohjoh H. Long-lasting RNAi activity in mammalian neurons. FEBS Lett 2004; 558: 89-95.
  • 10Schiitze N. At the cutting edge: siRNA technology. Mol Cell Endocrinol 2004; 213:115-9.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部